Kakkasseril J S, Cranley J J, Arbaugh J J, Roedersheimer L R, Welling R E
Arch Surg. 1985 Apr;120(4):427-9. doi: 10.1001/archsurg.1985.01390280021004.
In a review of 35 patients undergoing local thrombolysis using selective infusion of low-dose streptokinase, the overall success rate was 43%. Streptokinase appears to be most effective in occlusion of native arteries, in high-flow segments, and in autogenous saphenous vein grafts. Local streptokinase was least effective in occluded prosthetic grafts in the femoropopliteal segment (19% success). Distal embolization and progression of thrombosis of the distal arterial tree may occur while the patient is undergoing local thrombolysis and may result in limb loss. Hence, local thrombolysis is not recommended when surgical treatment is an alternative. Despite the low dose, systemic fibrinolytic effects and hemorrhagic complications were common occurrences; hence, routine hematologic monitoring is mandatory in patients undergoing lytic therapy with local infusion of streptokinase.
在一项对35例采用低剂量链激酶选择性输注进行局部溶栓治疗的患者的回顾性研究中,总体成功率为43%。链激酶似乎在以下情况最为有效:天然动脉闭塞、高血流节段以及自体大隐静脉移植血管。局部链激酶在股腘段人工血管闭塞中效果最差(成功率为19%)。在患者接受局部溶栓治疗时,可能会发生远端栓塞以及远端动脉树血栓形成的进展,并可能导致肢体丧失。因此,当有手术治疗选择时,不建议进行局部溶栓。尽管使用低剂量,但全身纤溶作用和出血并发症很常见;因此,对于接受局部输注链激酶进行溶栓治疗的患者,常规血液学监测是必需的。